Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-24-000014

Chief Financial Officer acquired 55,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2024-01-23 Grant or award +55,250 249,855 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2024-01-23 Grant or award · Stock Option (Right to Buy) +110,500 110,500 D: show line 2 in the form
Loading xslF345X05/wk-form4_1706133428.xml…